a study comparing the effect of metronidazol and tinidazol in treating Bacterial vaginosis (BV)
Phase 4
Completed
- Conditions
- Health Condition 1: N760- Acute vaginitisHealth Condition 2: null- bacterial vaginosis
- Registration Number
- CTRI/2014/04/004557
- Lead Sponsor
- Dr Indu M raja
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
women diagnosed with bacterial vaginosis
Exclusion Criteria
pregnant and lactating mothers, history of smoking and alcohol, previous history of bactrial vaginosis, with STDs, HIV or genital malignancies, antimicrobial use in previous 14 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method compare the cure rate of oral metronidazol with tinidazolTimepoint: compare the cure rate at the end of 5 days of oral metronidazol with tinidazol
- Secondary Outcome Measures
Name Time Method compare adverse effects of metronidazol with tinidazolTimepoint: 5days